Current studies have found that FAM64A was remarkably highly expressed in tumor tissues and cells of patients with leukemia [7], breast cancer [8], and pancreatic cancer [9], which may be related to cell cycle disorders, but its specific molecular mechanism is still unclear. Here, PIMREG is linked to breast cancer.